Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: A double-blind, placebo-controlled study

Hepatology ◽  
1992 ◽  
Vol 16 (5) ◽  
pp. 1180-1186 ◽  
Author(s):  
P. Aiden McCormick ◽  
Maria Rosa Biagini ◽  
Robert Dick ◽  
Lynda Greenslade ◽  
Jason Chin ◽  
...  
Keyword(s):  
Portal Hypertension ◽  
Venous Pressure ◽  
Portal Venous Pressure ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cirrhotic Patients

Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study

2015 ◽  
Vol 110 (7) ◽  
pp. 985-992 ◽  
Author(s):  
Enric Reverter ◽  
Francisco Mesonero ◽  
Susana Seijo ◽  
Javier Martínez ◽  
Juan G Abraldes ◽  
...  
Keyword(s):  
Portal Hypertension ◽  
Systemic Hemodynamics ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

The effect of flumazenil on subclinical psychometric orneurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study

1997 ◽  
Vol 17 (5) ◽  
pp. 533-539 ◽  
Author(s):  
P. Amodio ◽  
P. Marchetti ◽  
F. Del Piccolo ◽  
A. Beghi ◽  
F. Comacchio ◽  
...  
Keyword(s):  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cirrhotic Patients

884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159

2004 ◽  
Vol 171 (4S) ◽  
pp. 234-234 ◽  
Author(s):  
Harin Padma-Nathan ◽  
Jae Seung Pacik ◽  
Byoung Ok Ahn ◽  
Kyung Koo Kang ◽  
Mi Young Bahng ◽  
...  
Keyword(s):  
Phase I ◽  
Controlled Study ◽  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Male Subjects
Sign in / Sign up

Export Citation Format

Share Document